— Know what they know.
Not Investment Advice

OPGN OTC

OpGen, Inc.
1W: -4.4% 1M: -24.7% 3M: +91.6% YTD: +43.2% 1Y: +896.2% 3Y: +82.5% 5Y: -96.0%
$23.91
Last traded 2026-03-20 — delisted
OTC · Healthcare · Medical - Diagnostics & Research · $242.7M mcap · 2M float · 0.348% daily turnover · Short 30% of daily vol

Cash Flow Trends

Operating Cash Flow
-$5M +66.0% ▲
Capital Expenditures
$4 +100.0% ▲
5Y CAGR: -83.4%
Free Cash Flow
-$5M +67.8% ▲
Dividends Paid
$0 +0.0% ▲
Buybacks
$0 +0.0% ▲
Net Change in Cash
$159K +102.5% ▲

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2020FY2021FY2022FY2023FY2024
— Operating Activities —
Net Income-$26M-$35M-$37M-$33M$12M
Depreciation & Amort.$2M$3M$2M$1M$175K
Stock-Based Comp.$316K$879K$951K$236K$602K
Change in Working Capital-$2M-$2M-$2M-$1M-$4M
Other Non-Cash Items$3M$4M$16M$18M-$14M
Operating Cash Flow-$23M-$21M-$20M-$14M-$5M
— Investing Activities —
Capital Expenditures-$130K-$2M-$591K-$800K$0
Acquisitions (Net)$1M$0$0$0$0
Investment Purchases$0$0$0$0$0
Investment Sales$0$0$0$0$0
Other Investing-$2M-$2M$0$0$0
Investing Cash Flow-$1M-$2M-$591K-$800K$0
— Financing Activities —
Net Debt Issuance$294K-$708K-$11M-$4M$90K
Stock Repurchased$0$0$0$0$0
Dividends Paid$0$0$0$0$0
Other Financing$9M$9M$0$0$0
Financing Cash Flow$34M$47M-$7M$8M$5M
Net Change in Cash$11M$23M-$29M-$6M$159K
Cash End of Period$14M$37M$8M$1M$2M
Free Cash Flow-$24M-$23M-$21M-$15M-$5M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms